Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics

Contemporary Clinical Trials

Volumn 30, Issue 5, 2009, Pages 481-489

  Berg, Karina M ^a   Mouriz, Jennifer ^a   Li, Xuan ^a   Duggan, Elise ^a   Goldberg, Uri ^a   Arnsten, Julia H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; Directly observed therapy; HIV; Medication adherence; Methadone; Randomized trial; Substance abuse treatment

Indexed keywords

ANTIRETROVIRUS AGENT; METHADONE; NUCLEOSIDE DERIVATIVE; OPIATE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DIRECTLY OBSERVED THERAPY; DISTRESS SYNDROME; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG USE; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; OPIATE ADDICTION; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT COMPLIANCE; PILL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SCREENING TEST; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS LOAD; HIV INFECTIONS; MASS SCREENING; MEDICATION COMPLIANCE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

AMBULATORY CARE FACILITIES; ANALGESICS, OPIOID; ANTI-HIV AGENTS; DIRECTLY OBSERVED THERAPY; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MEDICATION ADHERENCE; METHADONE; MIDDLE AGED; SAMPLE SIZE; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 68349101321     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2009.05.003     Document Type: Article

References (31)

1. Arnsten J.H., Demas P.A., Grant R.W., et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 17 5 (2002) 377-381
2. Halkitis P.N., Kutnick A.H., and Slater S. The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states. J Health Psychol 10 4 (2005) 545-558
3. Gatt S., and Sammut R. An exploratory study of predictors of self-care behaviour in persons with type 2 diabetes. Int J Nurs Stud (2008)
4. Simoni J.M., Frick P.A., Pantalone D.W., and Turner B.J. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med 11 6 (2003) 185-198
5. Chaulk C.P., and Kazandjian V.A. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the Public Health Tuberculosis Guidelines Panel. JAMA 279 12 (1998) 943-948
6. Weis S.E., Slocum P.C., Blais F.X., et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 330 17 (1994) 1179-1184
7. Altice F.L., Mezger J.A., Hodges J., et al. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clin Infect Dis 38 Suppl 5 (2004) S376-S387
8. Mitty J.A., Macalino G.E., Bazerman L.B., et al. The use of community-based modified directly observed therapy for the treatment of HIV-infected persons. J Acquir Immune Defic Syndr 39 5 (2005) 545-550
9. Babudieri S., Aceti A., D'Offizi G.P., Carbonara S., and Starnini G. Directly observed therapy to treat HIV infection in prisoners. JAMA 284 2 (2000) 179-180
10. Conway B., Prasad J., Reynolds R., et al. Directly observed therapy for the management of HIV-infected patients in a methadone program. Clin Infect Dis 38 Suppl 5 (2004) S402-S408
11. Lucas G.M., Weidle P.J., Hader S., and Moore R.D. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clin Infect Dis 38 Suppl 5 (2004) S409-S413
12. Lucas G.M., Mullen B.A., McCaul M.E., Weidle P.J., Hader S., and Moore R.D. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care STDS 21 8 (2007) 564-574
13. Tossonian H.K., Raffa J.D., Grebely J., et al. Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program. J Acquir Immune Defic Syndr 45 3 (2007) 324-327
14. McCance-Katz E.F., Gourevitch M.N., Arnsten J., Sarlo J., Rainey P., and Jatlow P. Modified directly observed therapy (MDOT) for injection drug users with HIV disease. Am J Addict 11 4 (2002) 271-278
15. Molina J.M., Journot V., Morand-Joubert L., et al. Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. J Infect Dis 191 6 (2005) 830-839
16. Horberg M., Silverberg M., Hurley L., Delorenze G., and Quesenberry C. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens. AIDS Patient Care STDS 22 4 (2008) 301-312
17. Cooperman N.A., Arnsten J.H., and Klein R.S. Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev 19 4 (2007) 321-333
18. Arnsten J.H., Demas P.A., Farzadegan H., et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis 33 8 (2001) 1417-1423
19. Berg K.M., Demas P.A., Howard A.A., Schoenbaum E.E., Gourevitch M.N., and Arnsten J.H. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 19 11 (2004) 1111-1117
20. Diggle P.J., Heagerty P., Liang K.-Y., and Zeger S.L. Analysis of longitudinal data (2002), Oxford University Press, New York
21. Simoni J.M., Kurth A.E., Pearson C.R., Pantalone D.W., Merrill J.O., Frick P.A., Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227-45.
22. Johnson V.A., Brun-Vezinet F., Clotet B., et al. Update of the drug resistance mutations in HIV-1: spring 2008. Top HIV Med 16 1 (2008) 62-68
23. Clarke S., Keenan E., Ryan M., Barry M., and Mulcahy F. Directly observed antiretroviral therapy for injection drug users with HIV infection. AIDS Read 12 7 (2002) 305-306
24. Chesney M.A. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr 43 Suppl 1 (2006) S149-S155 S149-55.
25. Berg K.M., and Arnsten J.H. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr 43 Suppl 1 (2006) S79-S87
26. Liu H., Golin C.E., Miller L.G., et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 134 10 (2001) 968-977
27. DiMatteo M.R., Giordani P.J., Lepper H.S., and Croghan T.W. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40 9 (2002) 794-811
28. DiMatteo M.R. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42 3 (2004) 200-209
29. Howard A.A., Arnsten J.H., Lo Y., et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 16 16 (2002) 2175-2182
30. Altice F.L., Maru D.S., Bruce R.D., Springer S.A., and Friedland G.H. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis 45 6 (2007) 770-778
31. Macalino G.E., Hogan J.W., Mitty J.A., et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS 21 11 (2007) 1473-1477